Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Zanamivir

API Standards
CAT No.
:
CS-O-30822

CAS No.

:

139110-80-8

Molecular Weight

:

332.31

Molecular Formula

:

C12H20N4O7

Purity

:

>98%

Long Term Storage

:

-20° C

Inventory Status:

:

Available for Immediate Shipment
 

Purchase Online

Price 1 ( USD ) :

100.00 / 25mg

X

Units

Price 2 ( USD ) :

150.00 / 50mg

X

Units




Money
Back Guarantee

48 Hours Delivery
(For In-stock compounds)

Online
Purchase Protection


Useful information

"Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.",""



Product Application Notes

Zanamivir is a sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sial



Synonyms

4-Guanidino-Neu5c2en



References

Coenen, S. (2013);"2008-2009 Influenza Season Week 32 ending August 15, 2009"



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Zanamivir Cas # 139110-80-8 and its API Standards.

Zanamivir Zanamivir Worldwide Suppliers of Zanamivir API Standards Clearsynth 139110-80-8

Regular price: $100 In stock

Product rating: 9 Zanamivir based on 20 ratings

  1. API Standards

  2. Zanamivir



Keywords

Keywords: API Standards 4-Guanidino-Neu5c2en CS-O-30822 Zanamivir Zanamivir 139110-80-8 332.31 C12H20N4O7
Internal standard, Internal standard Zanamivir, HPLC-MS method validation, HPLC-MS method validation Zanamivir, LC-MS-MS method validation, LC-MS-MS method validation Zanamivir, Deuterated internal standard, Deuterated internal standard Zanamivir, Deuterated Zanamivir, Deuterium labeled Zanamivir, Quantitative bioanalytical methods, Quantitative bioanalytical methods Zanamivir, Blood samples Zanamivir, Blood concentrations, Heavy drugs, Analysis, Analysis Zanamivir, Clinical diagnostic, Clinical diagnostic Zanamivir, Dosing Zanamivir, Analytical method development, Internal standard method.



Related result for 'Zanamivir'

- Zanamivir : API Standards

- Zanamivir : Intermediates



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945